Panacea Biotec Limited (PANACEABIO.NS)

INR 522.95

(5.0%)

Net Income Summary of Panacea Biotec Limited

Panacea Biotec Limited's latest annual net income in 2023 was -11.73 Million INR , up 96.53% from previous year.
Panacea Biotec Limited's latest quarterly net income in 2024 Q1 was -158 Million INR , down -1004.9% from previous quarter.
Panacea Biotec Limited reported an annual net income of -337.5 Million INR in 2022, down -103.13% from previous year.
Panacea Biotec Limited reported an annual net income of 10.78 Billion INR in 2021, up 830.09% from previous year.
Panacea Biotec Limited reported a quarterly net income of -11.7 Million INR for 2023 FY, up 96.53% from previous quarter.
Panacea Biotec Limited reported a quarterly net income of 109.8 Million INR for 2023 Q1, up 186.59% from previous quarter.

Annual Net Income Chart of Panacea Biotec Limited (2023 - 2004)

Historical Annual Net Income of Panacea Biotec Limited (2023 - 2004)

Year	Net Income	Net Income Growth
2023	-11.73 Million INR	96.53%
2022	-337.5 Million INR	-103.13%
2021	10.78 Billion INR	830.09%
2020	-1.47 Billion INR	23.97%
2019	-1.94 Billion INR	-614.93%
2018	377.27 Million INR	149.64%
2017	-759.97 Million INR	-17.9%
2016	-644.6 Million INR	-252.43%
2015	-182.9 Million INR	82.83%
2014	-1.06 Billion INR	5.01%
2013	-1.12 Billion INR	52.14%
2012	-2.34 Billion INR	-13.92%
2011	-2.05 Billion INR	-255.24%
2010	1.32 Billion INR	82.95%
2009	724.12 Million INR	209.73%
2008	-659.92 Million INR	-151.16%
2007	1.28 Billion INR	-12.64%
2006	1.47 Billion INR	149.2%
2005	592.46 Million INR	117.09%
2004	272.91 Million INR	0.0%

Year	Net Income	Net Income Growth
2024 Q1	-158 Million INR	-1004.9%
2023 FY	-11.7 Million INR	96.53%
2023 Q1	109.8 Million INR	186.59%
2023 Q2	-82.9 Million INR	-175.5%
2023 Q3	-22.8 Million INR	72.5%
2023 Q4	-14.3 Million INR	37.28%
2022 Q2	157 Million INR	127.97%
2022 Q4	-126.8 Million INR	-165.46%
2022 FY	-337.5 Million INR	-103.13%
2022 Q1	-561.4 Million INR	-104.54%
2022 Q3	193.7 Million INR	23.38%
2021 Q4	12.37 Billion INR	2615.13%
2021 FY	10.78 Billion INR	830.09%
2021 Q3	-492 Million INR	7.19%
2021 Q1	-573.5 Million INR	-5.84%
2021 Q2	-530.1 Million INR	7.57%
2020 FY	-1.47 Billion INR	23.97%
2020 Q4	-541.86 Million INR	-35.3%
2020 Q3	-400.5 Million INR	-107.19%
2020 Q2	-193.3 Million INR	43.36%
2020 Q1	-341.3 Million INR	51.02%
2019 Q2	-750 Million INR	-165.3%
2019 Q3	-213.2 Million INR	71.57%
2019 Q4	-696.77 Million INR	-226.82%
2019 FY	-1.94 Billion INR	-614.93%
2019 Q1	-282.7 Million INR	-115.2%
2018 Q4	1.85 Billion INR	1266.42%
2018 Q2	-970 Million INR	-175.1%
2018 Q1	-352.6 Million INR	0.0%
2018 FY	377.27 Million INR	149.64%
2018 Q3	-159.4 Million INR	83.57%
2017 FY	-759.97 Million INR	-17.9%
2016 FY	-644.6 Million INR	-252.43%
2015 FY	-182.9 Million INR	82.83%
2014 FY	-1.06 Billion INR	5.01%
2013 FY	-1.12 Billion INR	52.14%
2012 FY	-2.34 Billion INR	-13.92%
2011 FY	-2.05 Billion INR	-255.24%
2010 FY	1.32 Billion INR	82.95%
2009 FY	724.12 Million INR	209.73%
2008 FY	-659.92 Million INR	-151.16%
2007 FY	1.28 Billion INR	-12.64%
2006 FY	1.47 Billion INR	149.2%
2005 FY	592.46 Million INR	117.09%
2004 FY	272.91 Million INR	0.0%

Peer Net Income Comparison of Panacea Biotec Limited

Name	Net Income	Net Income Difference
Biocon Limited	10.22 Billion INR	100.115%
Blue Jet Healthcare Limited	1.63 Billion INR	100.716%
Concord Biotech Limited	3.08 Billion INR	100.381%
Dishman Carbogen Amcis Limited	-1.53 Billion INR	99.236%
Jubilant Ingrevia Limited	1.82 Billion INR	100.641%
Lyka Labs Limited	-24.89 Million INR	52.88%
Piramal Pharma Limited	178.2 Million INR	106.582%
SMS Lifesciences India Limited	90.92 Million INR	112.9%
Supriya Lifescience Limited	1.19 Billion INR	100.985%
Syngene International Limited	5.1 Billion INR	100.23%
TAKE Solutions Limited	-1.19 Billion INR	99.019%
Zota Health Care Limited	-143.47 Million INR	91.825%